Tuesday, July 29, 2003
United States Patent and Trademark Office
Arlington, Virginia 22202
Patent Academy, Crystal Square 4, 7th Floor
The most recent quarterly meeting for the
Biotechnology and Chemical Pharmaceutical Customer Partnership was held on
April 29, 2003, at the U.S. Patent and Trademark Office. The Biotechnology
and Chemical Pharmaceutical Customer Partnership is designed and developed
to be a forum to share ideas, experiences, and insights between individual
users and the USPTO. The USPTO does not intend to use these customer
partnership groups to arrive at any consensus. Invitations to participate
will indicate that individual opinions are sought, rather than a group
consensus and that the meetings are intended to be informal in nature and
have varying participants. These customer partnership groups are formed
with full recognition of the USPTO’s responsibility under the Federal
Advisory Committee Act (FACA), and that these customer partnership groups
are not established as FACA compliant committees.
We value our
customers in obtaining feedback from individual participants is important
in our efforts to continuously improve the quality of our products and
services. Your willing participation is helpful in providing us with
insights and experiences in this informal process to assist us.
The next meeting of
the US Patent and Trademark Office Biotechnology and Chemical
Pharmaceutical Customer Partnership is scheduled for Tuesday , July 29,
2003 from 9:00 am to 4:30pm, Patent Academy, Crystal Square 4, 7th Floor,
located on 1745 Jefferson Davis Highway, Arlington, Virginia.
Please contact
Cecilia Tsang at 703-308-0254 or by fax at 703-746-7144 or email Cecilia.Tsang@uspto.gov
or contact Sharlamar Taliaferro at 703-306-4094 or by fax 703-305-8002 or
email Sharlamar.Taliaferro@uspto.gov
to decline or confirm your attendance.
Morning Session |
|
|
9:00 – 9:15 AM |
Greetings and Overview |
Jasemine Chambers John Doll
Bruce Kisliuk
Directors, TC 1600 |
9:15 – 10:15 AM |
New Rules Package
6-30-2003 |
OPLA |
10:15 – 10:30 AM |
Break |
|
10:30 – 11:15 AM |
Examiner Enablement Training |
Robert Hill |
11:15 – 11:45 AM |
Examiner Practice under
In re Baird/In re Ochiai |
James Wilson, SPE
AU 1623 |
|
LUNCH
11:45 PM-1:00PM |
|
Afternoon Session |
|
|
1:00-1:45 PM |
Reach-Through Claims |
(TBA-Page/Richter/Elliott) |
1:45 – 2:30 PM |
% Homology Claims |
Brian Stanton, QAS TC 1600 |
1:45 – 2:30 PM |
Break |
|
2:45 – 3:15 PM |
EFS/Pair |
SIRA |
3:15 – 3:45 PM |
Unity Study Overview |
Bruce Kisliuk, Director TC 1600 |
3:45 – 4:00 PM |
Closing Remarks |
Jasemine Chambers John Doll
Bruce Kisliuk
Directors, TC 1600 |
|